Baxter CEO: Heparin contamination seems deliberate

WASHINGTON (Reuters) - A contaminant in Baxter International Inc's recalled blood-thinner heparin appears to have been deliberately added, the company's chief executive said in testimony prepared for a congressional hearing on Tuesday examining imports of the drug from China.

Continue to Baxter CEO: Heparin contamination seems deliberate on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz